Brian L. Lin, PhD
Assistant Professor
Locations
- Cell Biology, Neurobiology and Anatomy
Contact Information
Education
PhD, Loyola University, 2016
BS, Miami University, 2008
Biography
Brian Lin started his research career in marine biology during his undergraduate studies at Miami University, where Brian also studied skeletal muscle in birds and amphibians. After graduating in 2008, Brian worked as a behavioral neuroscience technician at Cincinnati Children's Hospital and Northwestern University. From 2011-2016, Brian studied cell and molecular physiology at Loyola University Chicago focusing on the role of skeletal muscle myofilament proteins in the lab of Sakthivel Sadayappan. From 2016-2023, Brian studied the role of TRP channels in heart and kidney disease in the lab of David Kass in the Division of Cardiology at Johns Hopkins. From that work, Brian focused on the role of TRPC6 in the context of Duchenne muscular dystrophy for which he was awarded a K99/R00 award. Brian started his independent lab in the Department of Cell Biology, Neurobiology, and Anatomy at the Medical College of Wisconsin, where he continues to study novel therapeutics targeting TRP channels to treat dystrophic cardiomyopathy.
Research Interests
We study mechanical signaling in the heart in the context of muscular dystrophy. These diseases are commonly associated with skeletal muscle dysfunction, such as severe muscle weakness and the loss of the ability to walk. Our focus is on the damage to the heart, because most patients with muscular dystrophy die from heart failure.
Our lab applies spatial transcriptomics, animal models of heart disease, single cardiomyocyte biomechanics, in silico drug discovery, nanoparticle drug delivery, and human stem cell engineering platforms to enable testing and screening of exciting new therapies to treat muscular dystrophy and beyond.
Publications
-
(Akins KA, Arkatkar A, Flinn MA, Sandor N, Purdy AL, Brusacoram AL, Swift SK, Buday S, Choudhury P, Cui M, Lin BL, O'Meara CC, Patterson M.) JACC Basic Transl Sci. 2026 Feb;11(2):101455 PMID: 41534459 PMCID: PMC12830150 01/15/2026
-
GSNOR deletion differentially alters age-related cardiac function in a sex-dependent manner.
(Ebenebe OV, Kabir R, Booher A, Garbus H, Cohen CD, Jani V, Lin BL, Adamo L, Kohr MJ.) Am J Physiol Heart Circ Physiol. 2026 Jan 01;330(1):H253-H264 PMID: 41407313 12/18/2025
-
(Golosova D, Kumar G, Chaihongsa N, Reho JJ, Lu KT, Brozoski DT, Wackman KK, Lawton SBR, Muskus PC, Lin BL, Grobe JL, Nakagawa P, Sigmund CD.) Hypertension. 2025 Jul;82(7):1208-1220 PMID: 40440505 PMCID: PMC12176512 SCOPUS ID: 2-s2.0-105005164668 05/29/2025
-
(Taube N, Steiner M, Ebenebe-Kasonde OV, Kabir R, Garbus-Grant H, Alam El Din SM, Illingworth E, Wang N, Lin BL, Kohr MJ.) Am J Physiol Heart Circ Physiol. 2025 Mar 01;328(3):H460-H471 PMID: 39888327 PMCID: PMC12226173 01/31/2025
-
(Meddeb M, Koleini N, Jun S, Keykhaei M, Farshidfar F, Zhao L, Kwon S, Lin B, Keceli G, Paolocci N, Hahn V, Sharma K, Pearce EL, Kass DA.) bioRxiv. 2024 Jun 10 PMID: 38915649 PMCID: PMC11195057 06/25/2024
-
A transcriptional enhancer regulates cardiac maturation.
(Htet M, Lei S, Bajpayi S, Gangrade H, Arvanitis M, Zoitou A, Murphy S, Chen EZ, Koleini N, Lin BL, Kwon C, Tampakakis E.) Nat Cardiovasc Res. 2024 Jun;3(6):666-684 PMID: 39196225 PMCID: PMC12306338 08/28/2024
-
Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy.
(Hart CC, Lee YI, Xie J, Gao G, Lin BL, Hammers DW, Sweeney HL.) JCI Insight. 2024 May 07;9(11) PMID: 38713520 PMCID: PMC11382885 05/07/2024
-
Hypereosinophilia causes progressive cardiac pathologies in mice.
(Diny NL, Wood MK, Won T, Talor MV, Lukban C, Bedja D, Wang N, Kalinoski H, Daoud A, Talbot CC Jr, Leei Lin B, Čiháková D.) iScience. 2023 Oct 20;26(10):107990 PMID: 37829205 PMCID: PMC10565781 10/13/2023
-
Cadmium exposure induces a sex-dependent decline in left ventricular cardiac function.
(Fitch ML, Kabir R, Ebenebe OV, Taube N, Garbus H, Sinha P, Wang N, Mishra S, Lin BL, Muller GK, Kohr MJ.) Life Sci. 2023 Jul 01;324:121712 PMID: 37100378 PMCID: PMC10246466 04/27/2023
-
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.
(Reyes Gaido OE, Pavlaki N, Granger JM, Mesubi OO, Liu B, Lin BL, Long A, Walker D, Mayourian J, Schole KL, Terrillion CE, Nkashama LJ, Hulsurkar MM, Dorn LE, Ferrero KM, Huganir RL, Müller FU, Wehrens XHT, Liu JO, Luczak ED, Bezzerides VJ, Anderson ME.) Sci Transl Med. 2023 Jun 21;15(701):eabq7839 PMID: 37343080 PMCID: PMC11022683 06/21/2023
-
(Kannan S, Miyamoto M, Zhu R, Lynott M, Guo J, Chen EZ, Colas AR, Lin BL, Kwon C.) Cell Rep. 2023 Apr 25;42(4):112330 PMID: 37014753 PMCID: PMC10545814 04/05/2023
-
(Lin BL, Shin JY, Jeffreys WP, Wang N, Lukban CA, Moorer MC, Velarde E, Hanselman OA, Kwon S, Kannan S, Riddle RC, Ward CW, Pullen SS, Filareto A, Kass DA.) JCI Insight. 2022 Oct 10;7(19) PMID: 36099033 PMCID: PMC9675567 09/14/2022